We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reneuron Group Plc | LSE:RENE | London | Ordinary Share | GB00BF5G6K95 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.05 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 530k | -5.41M | -0.0946 | -0.32 | 1.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/6/2015 16:12 | guarantee they will publish figures sometime before 6pm tue 30th june. as they will not want the red flag raised otherwise! | rocket fuel | |
22/6/2015 16:07 | Did I not ask first? | investordave | |
22/6/2015 16:01 | and you have not answered mine! | rocket fuel | |
22/6/2015 16:00 | Rf - You haven't answered my question. | investordave | |
22/6/2015 15:50 | ID, please tell me from where, or what product are rene going to turn a £26m profit from revenues of £40m? from sales of what exactly? tell me what product will have completely finished trials and have gone trough FDA approvals, through manufacturing and marketing and ringing in their cash tills by FY 2017? | rocket fuel | |
22/6/2015 15:43 | Rf - Are you invested in this company or are you just here to deramp it? Genuine question and no offence meant. | investordave | |
22/6/2015 15:18 | ElGordo, that article was published just four hrs after my post this am. looks like we are both bang on with the cash burn likely to increase to £12m but where the hell they got that £26m profit from £40m revs in FY17 is some kind of a deluded mystery. they obviously got that one mixed up with one of their other penny punting tips. | rocket fuel | |
22/6/2015 14:09 | So, I've obviously not been paying attention; could someone advise where this (very welcome) rapid and major uplift in revenues is expected to come from? "...looking ahead to financial year 2017, ReNeuron is forecast to post a pretax profit of £26m, as it is expected to see revenue increase from a very small amount to around £40m." From here - | elgordo | |
22/6/2015 13:02 | What about the IC then, seans66 : do you trust their opinion? After commenting on the company's news today, they say they have their 'buy' recommendation under review. Maybe that means they'll be even more keen to buy , with a 'double buy' rec. ! | dogwalker | |
22/6/2015 10:22 | Not sure who I would trust more on Rene - Neil Woodford or some poster called Rocketfuel? | seans66 | |
22/6/2015 10:13 | Interesting to see that Neil Woodford moved up to 26% at the end of last month... | 43rick | |
22/6/2015 09:51 | rf - thanks - so we would expect them to be down to about £5 million by the end of September 2105? - this on the basis of (from the Interims posted Nov 2104)- "Cash outflow from operations in the period increased to £4.83 million (2013: £3.42 million), reflecting the increase in operating costs in the period. The Group had cash, cash equivalents and bank deposits totalling £16.10 million as at 30 September 2014 (March 2014: £20.92 million)." and from II board - yesterday evening - "If Renes exosome research comes good we are on a real.winner. This fourth line isn't accounted in the current target share price If it's as good as the text (I could only absorb the key points) implies the potential market could be so big Rene wont have any problem getting a big brother involved with further development over and above current business plan funds." | 43rick | |
22/6/2015 09:38 | 43r, they officially have six months to report but it is like an informal sub clause that the nomads and brokers seem to go by (the raising of red flags and alarm bells ringing), and I have witnessed it on at least half a dozen Aim companies over the last 15 yrs. they have suspended 'due to financial clarification' for not reporting by the end of month three. a couple of them lifted the suspension later and reported within the six months but the others just rolled over and died. im not saying rene will suspend, I'm saying they have left it to the last possible moment because they are probably frantically finalising their fundraising package! | rocket fuel | |
22/6/2015 09:31 | rocket fuel - Why are you bothering to post here? Just curious since you appear to have such a downer on the company. | investordave | |
22/6/2015 09:15 | rocket fuel - An AIM company must publish annual audited accounts which must be sent to its shareholders without delay and in any event not later than six months after the end of the financial year to which they relate. and from the 18th June 2014 Prelims- "Guildford, UK, 18 June 2014: ReNeuron Group plc ("ReNeuron" or the "Company"), a leading UK-based stem cell company, is pleased to announce its preliminary results for the year ended 31 March 2014." So it looks to me that RENE have until the end of September to report on the year to end 31 March 2015, Please tell me if I am wrong... | 43rick | |
22/6/2015 09:14 | Yes but those 18 months will see me exit at 25p lol | bigspuds | |
22/6/2015 08:53 | the majority of Aim companies report within six weeks of FY. the dodgy ones leave it eight to ten weeks, but the real blaggers leave it right up until the eleventh hour. if this shower do not report within the next six trading days (by 6pm 30th june) then the share will have to be suspended! by leaving it to the very last week always tells a sorry story. brace yourselves for a colossal smash n grab dilution about to take place here! this company burns cash like no other i've seen. over £70m since ipo and not one penny returned in profit (nor will there ever be). cash burn going forward will be climbing to c£10m and £12m imo. this company is a good 5-7yrs away from any FDA approval but that does not matter because they will be lucky to be around for another 18 months! | rocket fuel | |
22/6/2015 07:47 | Oow rns. See this going up today | easwarareddy | |
19/6/2015 08:06 | Would to have bought more at 4.75 but that's life. Have a large chunk from 2.8 So can't complain! | yachtmaster2 | |
19/6/2015 06:41 | Seem to have found our base now, Zak's lot all left after their gains, some buyers now. Ready to start creeping up ahead news possibly | madengland | |
17/6/2015 14:12 | There's the bounce | bigspuds | |
15/6/2015 11:32 | Rf - you talk nonsense, go away | madengland | |
15/6/2015 10:26 | It's good to know you're still taking an interest RF, I've been worried about you. I look in here occasionally and expected several hysterical postings a day as the share price rose. You didn't do that and the price doubled in a matter of weeks. I think you have to take some responsibility for that and you need to get your work mojo back, I know you can do it! | trigger blade | |
15/6/2015 10:04 | hope you guys had fun here and made hay while the sun shined. fy figures due out any day now. will be looking for at least £8m cash burn for the year and another massive placing at a fair discount to current share price would not be surprised if they have already done a placing deal at a further massive discount for the bucket shop brokers, which might account for the algo bot selling over the last few trading days! | rocket fuel |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions